Photo of Megan Murray

Megan Murray, M.D., Sc.D.

Ronda Stryker and William Johnston Professor of Global Health, Harvard Medical School
Professor in the Department of Epidemiology, Harvard T.H. Chan School of Public Health
Associate Professor of Medicine, Brigham and Women's Hospital
Director of Research, Global Health & Social Medicine, Harvard Medical School

Megan Murray, MD, MPH, ScD is an epidemiologist and an infectious disease physician with over 25 years of experience in the management of TB programs and TB epidemiology, as well as the transmission dynamics of emerging infectious diseases. She is a Professor of Global Health and Social Medicine and an Associate Professor of Medicine at Harvard Medical School, where she leads the Global Health Research Core, a multidisciplinary group of researchers who work with the Global Health Delivery Partnership faculty and staff to develop its mission to link research to the teaching and service activities of the Partnership. She is also a Professor of Epidemiology at Harvard School of Public Health and the Director of Research at the Brigham and Women’s Hospital Division of Global Health Equity and its sister organization, Partners In Health.  Dr. Murray has conducted field studies in Peru, Rwanda, South Africa, Ukraine, Russia and the US, and has previously worked in Kenya, Niger and Pakistan. Her current interests include identifying ways to reduce the suffering caused by the health impacts of climate change, especially in low and middle income countries.

Address: 
Department of Global Health and Social Medicine
641 Huntington Avenue
Boston, MA 02115

Alternative email address: mmurray@hsph.harvard.edu

Dr. Murray’s research focuses on host and pathogen specific determinants of TB infection, disease and treatment outcomes. Much of her research is done in collaboration with the non-governmental organization Partners in Health and its Peru-based sister organization Socios en Salud. The joint team uses bacterial and human genetic and genomic tools to identify variants of interest and to understand the mechanisms of their interactions.

In addition to her work in Peru, Dr. Murray has conducted field studies in South Africa, Russia, the US, India, Indonesia, Sierra Leone, Pakistan, Niger and Rwanda. She serves as an editor for PLoS Medicine and for the European Journal of Epidemiology. She is currently a member of the Mass Consortium for Pathogen Readiness leadership team as well as Harvard University’s Covid Monitoring Committee. She has also served on numerous other committees, including the WHO’s TB-STAG, the Stop TB MDR Working Group, Harvard University Human Subjects Committee, the University’s Pandemic Flu Advisory Committee, the Institute of Medicine committee on Gulf War and Infectious Diseases, and multiple NIH study sections.

Are survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation study.
Authors: Authors: Cohen T, Colijn C, Finklea B, Wright A, Zignol M, Pym A, Murray M.
PLoS One
View full abstract on Pubmed
Emergent heterogeneity in declining tuberculosis epidemics.
Authors: Authors: Colijn C, Cohen T, Murray M.
J Theor Biol
View full abstract on Pubmed
Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission.
Authors: Authors: Cohen T, Colijn C, Finklea B, Murray M.
J R Soc Interface
View full abstract on Pubmed
Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis.
Authors: Authors: Lin HH, Ezzati M, Murray M.
PLoS Med
View full abstract on Pubmed
Antiviral resistance and the control of pandemic influenza.
Authors: Authors: Lipsitch M, Cohen T, Murray M, Levin BR.
PLoS Med
View full abstract on Pubmed
Blood screening for west nile virus: the cost-effectiveness of a real-time, trigger-based strategy.
Authors: Authors: Korves CT, Goldie SJ, Murray MB.
Clin Infect Dis
View full abstract on Pubmed
Causes of death during tuberculosis treatment in Tomsk Oblast, Russia.
Authors: Authors: Mathew TA, Ovsyanikova TN, Shin SS, Gelmanova I, Balbuena DA, Atwood S, Peremitin GG, Strelis AK, Murray MB.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.
Authors: Authors: Hazbón MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M, Billman-Jacobe H, Lavender C, Fyfe J, García-García L, León CI, Bose M, Chaves F, Murray M, Eisenach KD, Sifuentes-Osornio J, Cave MD, Ponce de León A, Alland D.
Antimicrob Agents Chemother
View full abstract on Pubmed
Cost-effectiveness of treating multidrug-resistant tuberculosis.
Authors: Authors: Resch SC, Salomon JA, Murray M, Weinstein MC.
PLoS Med
View full abstract on Pubmed
Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients.
Authors: Authors: Louw GE, Warren RM, Donald PR, Murray MB, Bosman M, Van Helden PD, Young DB, Victor TC.
Int J Tuberc Lung Dis
View full abstract on Pubmed